Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel, Cisplatin, and 5-Fluorouracil Induction Followed by Chemoradiotherapy in Advanced Head and Neck Cancer
NCT00054054Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Apr 2003
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of docetaxel, cisplatin and fluorouracil in head and neck squamous cell carcinoma (HNSCC), sponsored by SWOG Cancer Research Network. Primary endpoints: Overall Survival, Unconfirmed Complete Response Rate and 2 more. Started Apr 2003; status: completed.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00054054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00054054.